ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 32 filers reported holding ONCOSEC MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $133,000 | -33.8% | 274,196 | +0.7% | 0.00% | – |
| Q2 2022 | $201,000 | -35.6% | 272,252 | +0.3% | 0.00% | – |
| Q1 2022 | $312,000 | +24.3% | 271,484 | +3.4% | 0.00% | – |
| Q4 2021 | $251,000 | -51.8% | 262,478 | +7.1% | 0.00% | – |
| Q3 2021 | $521,000 | +1.2% | 245,011 | +33.7% | 0.00% | – |
| Q2 2021 | $515,000 | -23.6% | 183,322 | +29.7% | 0.00% | – |
| Q1 2021 | $674,000 | +28.1% | 141,335 | +73.1% | 0.00% | – |
| Q4 2020 | $526,000 | +209.4% | 81,662 | +61.9% | 0.00% | – |
| Q3 2020 | $170,000 | +65.0% | 50,429 | 0.0% | 0.00% | – |
| Q2 2020 | $103,000 | +90.7% | 50,429 | +17.1% | 0.00% | – |
| Q1 2020 | $54,000 | -64.9% | 43,073 | -50.0% | 0.00% | – |
| Q4 2019 | $154,000 | +83.3% | 86,146 | +100.0% | 0.00% | – |
| Q3 2019 | $84,000 | -22.2% | 43,073 | 0.0% | 0.00% | – |
| Q2 2019 | $108,000 | – | 43,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SALZHAUER MICHAEL | 277,312 | $591,000 | 0.24% |
| Avidity Partners Management LP | 2,945,000 | $6,273,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 316,229 | $674,000 | 0.12% |
| J. Goldman & Co LP | 790,242 | $1,683,000 | 0.08% |
| Sandbox Financial Partners, LLC | 25,000 | $53,000 | 0.04% |
| Virtu Financial LLC | 25,166 | $54,000 | 0.01% |
| D.A. DAVIDSON & CO. | 108,500 | $231,000 | 0.00% |
| J. Goldman & Co LP | 26,300 | $56,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 361,401 | $770,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 49,500 | $105,000 | 0.00% |